Fetal Alcohol Spectrum Disorder - Across the Lifespan

Fetal Alcohol Spectrum Disorder - Across the Lifespan: Presentations

Wed 7 Oct 2009 | Thu 8 Oct 2009 | Fri 9 Oct 2009

Fetal Alcohol Spectrum Disorder (FASD) – Across the Lifespan – Final Program


Conference Moderator: Nancy Reynolds, President and Chief Executive Officer, Alberta Centre for Child, Family and Community Research


Wednesday, 7 October 2009

08:00 – 08:20

  • Opening Remarks 
    The Honourable Iris Evans, Minister of Finance and Enterprise 
    The Honourable Janis Tarchuk, Minister of Children and Youth Services
     

08:20 – 09:05

QUESTION 1: What is Fetal Alcohol Spectrum Disorder (FASD) and how is it diagnosed?

  • Overview of FASD 
    Gail Andrew, Member, Board of Directors, Canada Northwest FASD Research Network; Medical Site Lead - Pediatrics, Medical Director - FASD Clinical Services and Pediatric Consultant, Pediatric Programs, Glenrose Rehabilitation Hospital 
    Download Presentation 
  • A personal perspective 
    Myles Himmelreich, Director of Programming, Canadian FASD Foundation
  • Jury question and answer 
     

09:05 – 12:00

QUESTION 2: Do we know the prevalence and incidence of FASD in different populations, and can the reporting be improved?

  • Prevalence and incidence in Alberta and Canada
    Suzanne Tough, Scientific Director, Alberta Centre for Child, Family and Community Research
    Download Presentation 
  • Prevalence and incidence internationally
    Philip May, Professor of Sociology and Family and Community Medicine, University of New Mexico; Senior Research Scientist, Center on Alcoholism, Substance Abuse, and Addictions 
    Download Presentation 
  • Jury question and answer 
  • Extent and impact on child development 
    Ben Gibbard, Developmental Pediatrician, Alberta Children's Hospital; Assistant Professor, Department of Pediatrics, Faculty of Medicine, University of Calgary 
    Download Presentation 
  • Prevalence of FAS in foster care
    Susan Astley, Professor of Epidemiology/Pediatrics, University of Washington; Director, Washington State Fetal Alcohol Syndrome Diagnostic and Prevention Network 
    Download Presentation 
  • Genetic pre-disposing factors 
    Albert Chudley, Medical Director, Winnipeg Regional Health Authority Program in Genetics and Metabolism; Professor, Department of Pediatrics, University of Manitoba 
    Download Presentation 
  • Direct and indirect mechanisms for alcohol damage to the brain 
    Joanne Weinberg, Professor and Distinguished University Scholar and Acting Department Head, Cellular and Physiological Sciences, University of British Columbia 
    Download Presentation 
  • Jury question and answer 
     

13:00 – 15:20

QUESTION 3: What are the consequences of FASD on individuals, their families and society?

  • Economic implications 
    Phil Jacobs, Professor, Gastroenterology Division, Department of Medicine, University of Alberta; Director of Collaborations, Institute of Health Economics 
    Download Presentation 
  • Consequences on the community
    Mary Berube, Director, Intergovernmental Initiatives, Ministry Support Services Division, Alberta Children and Youth Services 
    Download Presentation 
  • Impact on system usage within foster care 
    Linda Burnside, Executive Director, Disability Programs, Manitoba Family Services and Housing 
    Download Presentation 
  • Jury question and answer 
  • Co-morbidities with mental health for an individual with FASD 
    Dan Dubovsky, FASD Specialist for the Substance Abuse and Mental Health Services Administration (SAMHSA), FASD Center for Excellence 
    Download Presentation 
  • Consequences for communities supporting adults with FASD
    Diane Malbin, Executive Director, Fetal Alcohol Syndrome Consultation, Education and Training Services 
    Download Presentation 
  • Jury question and answer 
     

15:20 – 16:35

QUESTION 4: How can FASD be prevented?

  • Pre-conception initiatives 
    Lola Baydala, Associate Professor of Pediatrics, University of Alberta
  • Inventory of primary prevention campaigns 
    Robin Thurmeier, FASD Resources Researcher, Saskatchewan Prevention Institute 
    Download Presentation 
  • Primary care physician perspective 
    June Bergman, Associate Professor, Department of Family Medicine, Faculty of Medicine and Dentistry, University of Calgary 
    Download Presentation 
  • Jury question and answer 



Thursday, 8 October 2009

08:00 – 08:15

  • Opening Remarks
    Gail Andrew, Expert Chair
     

08:15 – 09:40

QUESTION 4: How can FASD be prevented? (continued)

  • Mentoring programs for at-risk mothers
    Nancy Whitney, Clinical Director, King County Parent-Child Assistance Program, University of Washington 
    Download Presentation 
  • Strength and support: A women's perspective 
    Amy Salmon, Managing Director, Canada Northwest FASD Research Network; Clinical Assistant Professor, School of Population and Public Health, Faculty of Medicine, University of British Columbia 
    Download Presentation 
  • Prevention of FASD: A Broader Strategy in women's Health 
    Nancy Poole, Research Associate, British Columbia Centre of Excellence for Women's Health; Research Consultant, Women and Substance Use Issues, British Columbia Women's Hospital 
    Download Presentation
  • Jury Question and Answer 

09:40 – 14:40

QUESTION 5: What policy options could more effectively support individuals with FASD and their families across the lifespan?

  • Educational system, parental, and community support 
    Frank Oberklaid, Director, Centre for Community Child Health, Royal Children's Hospital, and Professor, Pediatrics, University of Melbourne 
    Download Presentation 
  • Shifting responsibility from the individual to communities of care 
    Audrey McFarlane, Executive Director, Lakeland Centre for Fetal Alcohol Spectrum Disorder 
    Download Presentation 
  • Education policy 
    Elizabeth Bredberg, Education Consultant, Bredberg Research and Consulting in Education 
    Download Presentation 
  • Jury Question and Answer 
  • Development of life skills: education, parenting, and family mentoring 
    Claire Coles, Professor, Department of Psychiatry and Behavioral Sciences and Pediatrics, Emory University School of Medicine; Director, Fetal Alcohol and Drug Exposure Clinic, Marcus Autism Center, Children's Health Care of Atlanta 
    Download Presentation 
  • Life stages and transitions 
    Brenda Bennett, Executive Director, FASD Life's Journey Inc. 
    Download Presentation 
  • Social services and corrections 
    Sharon Brintnell, Professor, Department of Occupational Therapy, and Director, Occupational Performance Analysis Unit, Faculty of Rehabilitation Medicine, University of Alberta 
    Download Presentation 
  • Jury Question and Answer 
  • Treatment of FASD 
    John McLennan, Assistant Professor and Child Psychiatry Consultant, Departments of Community Health Sciences, Psychiatry, and Paediatrics, University of Calgary 
    Download Presentation 
  • Justice issues 
    Mary Kate Harvie, Associate Chief Judge, Provincial Court of Manitoba 
    Download Presentation 
  • Policy development in FASD 
    Dorothy Badry, Assistant Professor, Faculty of Social Work, University of Calgary 
    Download Presentation 
  • Jury Question and Answer 

15:00 – 16:30

QUESTION 6: What further research into FASD is needed?

  • Health and social policy 
    Sterling Clarren, CEO and Scientific Director, Canada Northwest FASD Research Network; Clinical Professor of Pediatrics, Faculty of Medicine, University of British Columbia; Clinical Professor of Pediatrics, University of Washington School of Medicine 
    Download Presentation 
  • Clinical 
    Sara Jo Nixon, Professor, Department of Psychiatry, University of Florida, Clinical and Translational Science Institute, Biobehavioral Core 
    Download Presentation 
  • Child health and well-being 
    Bruce Perry, Senior Fellow, The ChildTrauma Academy
  • Extended jury question and answer 



Friday, 9 October 2009 

09:00 – 11:00

  • Reading of the Consensus Statement by Jury Chair
    The Honourable Anne McLellan
  • Open discussion
  • Closing remarks
    The Honourable Anne McLellan, Jury Chair
    Gail Andrew, Expert Chair
    Egon Jonsson, Executive Director and Chief Executive Officer, Institute of Health Economics